You just read:

Valeant And One Of Its Subsidiaries Announce Upsize Of Cash Tender Offers To $1,500,000,000 Outstanding Principal Amount

News provided by

Valeant Pharmaceuticals International, Inc.

Mar 12, 2018, 19:42 ET